NSE · AARTIDRUGS
Aarti Drugs Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#936
of 5,072 stocks
▼ 91W
Peak #927 · 21 Sep 2026
Aarti Drugs Limited is a smallcap company in the Healthcare space and is growing revenue modestly, trades at a moderate earnings multiple, and earns a healthy return on equity.
Market Cap
3,900.88 Cr
P/E Ratio
20.01
P/B Ratio
2.52
ROE
12.58%
ROCE
12.92%
Dividend Yield
0.47%
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 702.78 Cr | 720.30 Cr | 601.71 Cr | 652.79 Cr |
| Net Profit | 50.13 Cr | 55.26 Cr | 40.55 Cr | 45.16 Cr |
| EPS | 5.49 | 6.05 | 4.44 | 4.95 |
| Operating Profit | 80.55 Cr | 78.52 Cr | 38.31 Cr | 68.11 Cr |
Shareholding pattern
Promoter
54.43%
Public
45.57%
Mutual fund holdings
₹378.69
Cr total
8
Schemes
5
Fund Houses
₹378.69 Cr
Total Exposure
DSP Mutual Fund₹298.07 Cr (78.7%)
ICICI Prudential Mutual Fund₹76.79 Cr (20.3%)
Motilal Oswal Mutual Fund₹3.81 Cr (1.0%)
Groww Mutual Fund₹0.03 Cr (0.0%)
Mirae Asset Mutual Fund₹0.00 Cr (0.0%)
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 09 Feb 2026 | Dividend | Interim Dividend - Rs 2 Per Share |
| 04 Feb 2025 | Dividend | Interim Dividend - Re 1 Per Share |
| 05 Sep 2024 | Buyback | Buy Back |
| 06 Feb 2024 | Dividend | Interim Dividend - Re 1 Per Share |
| 04 Aug 2023 | Buyback | Buy Back |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.